Form 483

Nitro Quimica Corporation dba Alchemix A Nitro Quimica Corporation Form 483, 2017-02-22

FDA issued a Form 483 to Nitro Quimica Corporation dba Alchemix A Nitro Quimica Corporation on 2017-02-22 with 11 public-safe observations.

483· Form 483 issuedHuman Drugs11 observations

Nitro Quimica Corporation dba Alchemix A Nitro Quimica Corporation · College Park, United States · Issued February 22, 2017

Overview

  • 11 public-safe observations are available for this inspection.
  • 10 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

22 Feb 2017
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Susan O Oladeji

22 Feb 2017
21 CFR 211.165(b)

Microbiological testing

Cited by Susan O Oladeji

22 Feb 2017
21 CFR 211.182

Written records kept in individual logs

Cited by Susan O Oladeji

22 Feb 2017
21 CFR 211.186(a)

Written procedures followed

Cited by Susan O Oladeji

22 Feb 2017
21 CFR 211.188

Prepared for each batch, include complete information

Cited by Susan O Oladeji

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(b)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.186(a)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.25(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 11 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere